Literature DB >> 16414340

Strategies and issues for managing menopause-related symptoms in diverse populations: ethnic and racial diversity.

Valerie Montgomery Rice1.   

Abstract

Menopause is a naturally occurring "equal opportunity" event that every woman who lives beyond the age of approximately 52 years will experience. During the next 20 years, approximately 3.5 million African American women, 2 million Latinas, and 1 million Asian American women will enter the menopause. How a woman approaches the menopausal transition depends on a number of factors, from educational level to socioeconomic status; health-related factors, including stress; and marital status. Increasingly, the roles of race and ethnicity, as they relate to menopausal symptoms, are being explored. Understanding similarities and differences among women of color in perceptions, attitudes, and expectations surrounding the menopause can help provide culturally appropriate care and promote lifestyles that may decrease symptoms and increase quality of life. For example, minority women are usually the gatekeepers for healthcare for themselves and their families and have a highly developed social support network, often including extended family, a church community, and involvement in sororal or social organizations. In the future, research on menopausal symptoms among women of different racial/ethnic groups should focus on exploring in greater detail the effect of dietary factors and body mass index, additional evaluation of pituitary sensitivity, and use of complementary and alternative medicines in symptom management, with a better understanding of the risks and benefits of such therapies.

Entities:  

Mesh:

Year:  2005        PMID: 16414340     DOI: 10.1016/j.amjmed.2005.09.048

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

1.  Efficacy and safety of bazedoxifene in postmenopausal Asian women.

Authors:  L Xu; K-S Tsai; G S Kim; Y Wu; P Vincendon; A A Chines; G D Constantine
Journal:  Osteoporos Int       Date:  2010-06-10       Impact factor: 4.507

Review 2.  Bazedoxifene: a review of its use in the treatment of postmenopausal osteoporosis.

Authors:  Sean T Duggan; Kate McKeage
Journal:  Drugs       Date:  2011-11-12       Impact factor: 9.546

3.  The day-to-day impact of urogenital aging: perspectives from racially/ethnically diverse women.

Authors:  Alison J Huang; Janis Luft; Deborah Grady; Miriam Kuppermann
Journal:  J Gen Intern Med       Date:  2009-11-12       Impact factor: 5.128

4.  Costs of hormonal and nonhormonal prescription medications for hot flashes.

Authors:  Amie Williams-Frame; Janet S Carpenter
Journal:  Womens Health (Lond)       Date:  2009-09

Review 5.  Empowerment and coping strategies in menopause women: a review.

Authors:  Mansoureh Yazdkhasti; Masoumeh Simbar; Fatemeh Abdi
Journal:  Iran Red Crescent Med J       Date:  2015-03-20       Impact factor: 0.611

6.  Effect of Health-Promoting Lifestyle Modification Education on Knowledge, Attitude, and Quality of Life of Postmenopausal Women.

Authors:  Nirmala Rathnayake; Gayani Alwis; Janaka Lenora; Iresha Mampitiya; Sarath Lekamwasam
Journal:  Biomed Res Int       Date:  2020-05-20       Impact factor: 3.411

7.  A survey of medical cannabis use during perimenopause and postmenopause.

Authors:  M Kathryn Dahlgren; Celine El-Abboud; Ashley M Lambros; Kelly A Sagar; Rosemary T Smith; Staci A Gruber
Journal:  Menopause       Date:  2022-08-02       Impact factor: 3.310

8.  Attitudes toward menopause in HIV-infected and at-risk women.

Authors:  Diana Hartel; Yungtai Lo; Carolyn Bauer; Nancy Budner; Andrea A Howard; Michelle Floris-Moore; Julia H Arnsten; Nanette Santoro; Ellie E Schoenbaum
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

9.  The Effect of Support Group Method on Quality of Life in Post-menopausal Women.

Authors:  M Yazdkhasti; M Keshavarz; Es Merghaati Khoei; Af Hosseini; S Esmaeilzadeh; M Amiri Pebdani; H Jafarzadeh
Journal:  Iran J Public Health       Date:  2012-11-01       Impact factor: 1.429

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.